Jasper Therapeutics, Inc. JSPR
NASDAQ · United States · Health Technology
$0.5650-0.03 (-5.52%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-14 | -0.10 | -0.27 | +62.7% | $0 | — | -2.4%$0.86→$0.84 |
| Q1 2026 | 2026-05-14 | -0.38 | -0.46 | +17.4% | — | — | -7.6%$0.92→$0.85 |
| Q4 2025 | 2026-03-30 | -0.54 | -0.82 | +34.1% | — | — | -16.6%$1.05→$0.88 |
| Q3 2025 | 2025-11-10 | -1.13 | -1.01 | -11.9% | — | — | -4.5%$1.78→$1.70 |
| Q1 2024 | 2024-05-14 | -1.03 | -1.18 | +12.7% | — | — | — |
| Q4 2023 | 2024-03-04 | -1.50 | -1.57 | +4.5% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.